Skin Substitute Fraud Defense: U.S. v. Ellsworth Analysis
United States v. Ellsworth, Kelly & Broadbent — An 18-count federal indictment charges a Utah podiatrist, a nurse practitioner, and a registered nurse with health care fraud, wire fraud, and false statements relating to health care matters in connection with approximately $61 million in Medicare billings for skin substitute services. The defense theme begins with what the indictment does not charge.
The Ellsworth Indictment in the Context of DOJ's Wound Care Initiative
On May 12, 2026, a federal grand jury in the District of Utah returned an 18-count indictment against podiatrist Ryan Scott Ellsworth, nurse practitioner Emilee Kelly, and registered nurse Drake Dell Broadbent. The charges arise from skin substitute services billed through Summit Foot and Ankle and Amble Medical, podiatry and wound care entities owned and operated by Ellsworth in St. George, Sandy, Provo, Payson, and West Valley City, Utah.
The case fits within the Department of Justice Fraud Section's Wound Care Initiative. In its 2025 Year in Review, the Fraud Section identified wound care as a top priority and described Medicare spending on skin substitutes as having "exploded." CMS reports that Medicare payments for skin substitutes grew from $256 million in 2019 to over $10 billion in 2024. Effective January 1, 2026, CMS reduced reimbursement rates for these products under a new methodology projected to cut spending by nearly 90 percent.
The criminal enforcement footprint is national. In October 2025, the District of Arizona sentenced Alexandra Gehrke and Jeffrey King to 15.5 and 14 years in prison after their guilty pleas to conspiracy to commit health care fraud and wire fraud in a $1.2 billion amniotic wound allograft scheme. In June 2025, a federal grand jury in the Southern District of Texas returned a superseding indictment of podiatrist David Jenson and his business partner Nestor Romero Magallanes on conspiracy, health care fraud, and money laundering counts for $90 million in skin substitute billing.
What the Indictment Alleges
The indictment charges three defendants under three federal statutes. Counts 1 through 8 charge health care fraud under 18 U.S.C. § 1347. Counts 9 through 16 charge wire fraud under 18 U.S.C. § 1343 for the interstate electronic transmission of the same claims from Summit's Sandy, Utah corporate office through TriZetto Provider Solutions in Earth City, Missouri to Noridian Healthcare Solutions in Fargo, North Dakota. Counts 17 and 18 charge Ellsworth and Broadbent with false statements relating to health care matters under 18 U.S.C. § 1035(a)(2) for patient chart entries that allegedly misrepresented who furnished skin substitute services and whether Medicare requirements were satisfied.
The Government's Theories of Falsity
The "manner and means" section of the indictment articulates four overlapping theories. First, at paragraph 22, that the defendants caused submission of claims for skin substitute services that were "medically unnecessary and not rendered as billed." Second, at paragraph 23, that the defendants billed for skin substitute applications on patients who "did not have qualifying wounds" because basic wound management had not been administered for the prior 30 days, citing Local Coverage Determination L38902 (Wound and Ulcer Care). Third, at paragraph 24, that the defendants billed for the continued and medically unnecessary use of skin substitutes on wounds. Fourth, at paragraph 26, that Ellsworth caused unqualified personnel, including Broadbent, to perform skin substitute services outside their professional scope of practice and billed those services under Ellsworth's own Medicare provider number.
The "not rendered as billed" phrase in paragraph 22 carries two distinct interpretations. One is a scope-of-practice theory: services were performed by clinical staff but billed under Ellsworth's NPI. The other is an upcoding theory: that the billed surface area, the billed CPT application code, the billed anatomic location, or the billed product Q code did not match what was actually applied. The indictment does not specify which interpretation the government will pursue, and the difference matters for the defense.
The indictment also alleges that the defendants routinely waived Medicare copayments for skin substitute services. The government characterizes copayment waiver as a fraud-facilitation device because consistent copayment collection gives beneficiaries a financial reason to refuse services that are not medically necessary. Copayment waiver is not separately charged.
The Charged Conduct and Billing Volume
| Defendant | Role | Billed to Medicare | Paid by Medicare |
|---|---|---|---|
| Ryan Scott Ellsworth | Podiatrist; owner of Summit Foot and Ankle and Amble Medical | ~$44 million (July 2021 – December 2025) | ~$19 million |
| Emilee Kelly | Registered nurse, then nurse practitioner at Summit-St. George | ~$17 million (2024 – December 2025) | ~$10 million |
| Drake Dell Broadbent | Registered nurse at Summit-St. George | Specific counts allege ~$238,550 in billed claims | ~$102,000 across charged claims |
What the Indictment Does Not Allege Matters As Much As What It Does
DOJ has been explicit that, in its view, the growth in skin substitute billing has been "driven by illegal kickbacks from wholesalers and medically unnecessary applications by providers incentivized by the high reimbursement rates." That is the language the Fraud Section used in its 2025 Year in Review. The Ellsworth indictment notably omits the kickback half of that theory.
No Allegation That Wound Care Services Were Fabricated or Never Provided
The indictment does not allege phantom services or ghost patients. It does not allege that any defendant billed for dates of service on which the clinic was closed, on which the provider was elsewhere, or on which the beneficiary was hospitalized, incarcerated, or deceased. It does not allege that any defendant billed Medicare for skin substitute applications that were never performed.
That contrast matters. The Gehrke and King indictment in Arizona alleged that nurse practitioners applied amniotic grafts to wounds that had already healed and to wounds that did not exist. The June 2025 superseding indictment of David Jenson and Nestor Magallanes in the Southern District of Texas alleged that the defendants applied skin substitutes to patients "that did not have qualifying wounds, or any wounds at all." The federal Botox indictment in the Central District of California alleged claims submitted on dates when the clinic was closed and when the beneficiary was in federal prison. None of those allegations appears in the Ellsworth indictment.
The "Not Rendered As Billed" Language Is Narrow and Conditional
The phrase "not rendered as billed" appears in only two paragraphs of the indictment. Paragraph 22 alleges generally that defendants caused submission of claims for services "medically unnecessary and not rendered as billed." Paragraph 27 alleges that Ellsworth's $44 million in claims were "many of which were medically unnecessary and, at times, not rendered as billed." The "at times" qualifier is significant.
Notably, paragraph 28's allegations against Emilee Kelly use only "medically unnecessary" without the "not rendered as billed" language. There is no defendant-specific paragraph alleging that Drake Broadbent personally billed services he did not perform. In context, the "not rendered as billed" theory appears to be a scope-of-practice theory rather than a phantom-services theory. The government's allegation is that services were performed by clinical staff outside their scope of practice and billed under Ellsworth's name and provider number, not that no services occurred.
No Conspiracy, No Kickbacks, No Money Laundering
The Ellsworth indictment contains no Anti-Kickback Statute count. There is no allegation that any defendant received remuneration from a skin substitute manufacturer, wholesaler, marketer, or distributor. There is no allegation of a referral payment, a per-application bonus, a rebate scheme, or any financial relationship with a product source. The government has not charged conspiracy under 18 U.S.C. § 1349 or any agreement among the three named defendants. The government has not charged money laundering under 18 U.S.C. §§ 1956 or 1957. The government has not charged aggravated identity theft, obstruction, or false statements to investigators.
That omission is significant. In federal criminal wound care prosecutions across the country, kickbacks are the engine of the government's fraud theory. The Gehrke and King indictment in the District of Arizona centered on more than $279 million in kickbacks paid by a wholesale graft distributor to a marketing company, with the company directing nurse practitioners to apply oversized grafts to hospice and elderly patients regardless of medical necessity. The June 2025 superseding indictment of Texas podiatrist David Jenson and his business partner Nestor Romero Magallanes paired health care fraud counts with conspiracy and money laundering counts and alleged the application of skin substitutes to patients without any wounds. Without those anchors, the Ellsworth case stands or falls on whether the government can prove beyond a reasonable doubt that the defendants knowingly billed for procedures performed on real patients with real wounds where the wounds did not meet a contestable interpretation of LCD L38902.
Why the Medical Necessity Theory Is Difficult to Prove
The government's case turns almost entirely on the medical necessity of skin substitute applications under LCD L38902. That LCD is highly technical. It requires interpretation. And it leaves substantial room for clinical judgment that does not amount to criminal fraud.
LCDs Are Not Statutes
Local Coverage Determinations are administrative documents issued by Medicare Administrative Contractors. They are not statutes. They are not regulations. They do not impose criminal liability. The Department of Health and Human Services itself has long described LCDs as guidance documents that explain when a contractor will pay for a service in a given jurisdiction. A claim submitted in noncompliance with an LCD may be subject to recoupment. It is not, without more, a federal crime.
The Ellsworth indictment acknowledges this complexity. At paragraph 14, the indictment states that "there were no controlling LCDs governing Medicare claims for the use of skin substitutes to treat wounds in Utah" during the charged period. The government's case rests on LCD L38902, which addresses "Wound and Ulcer Care" generally and references basic wound management, debridement, infection control, and documentation. The decision to extrapolate that general LCD to skin substitute applications is itself a contestable interpretive choice.
The 30-Day Conservative Care Requirement Involves Clinical Judgment
The indictment's central medical necessity theory is that skin substitute applications are permissible only after 30 days of failed conservative care. That standard is not codified in any LCD provision that defines a bright-line trigger for skin substitute coverage in Utah. Even applying LCD L38902 by analogy, the contractor language describes basic wound management consisting of debridement, pressure relief, compression, infection control, exudate management, moist wound environment, and control of comorbid conditions. Whether a particular patient received "30 days" of compliant basic care, whether the wound was "unchanged" or "lacking signs of improvement," and whether advanced wound care was clinically appropriate are all judgment calls. Reasonable clinicians can disagree.
That ambiguity matters for the government's burden of proof. Federal health care fraud under 18 U.S.C. § 1347 requires the prosecution to prove that the defendant acted "knowingly and willfully." Billing errors are not crimes. Documentation gaps are not crimes. Disagreement with a contractor's coverage interpretation is not a crime. Where the underlying coverage rule is itself ambiguous, the ambiguity favors the defendant.
The Heightened Mens Rea Standard Under the Tenth Circuit Pattern Jury Instructions
The defendants will be tried in the District of Utah, which sits within the Tenth Circuit. Tenth Circuit Pattern Criminal Jury Instruction 2.57, governing wire fraud under 18 U.S.C. § 1343, requires the government to prove three elements beyond a reasonable doubt. The second element is that the defendant "acted with specific intent to defraud," which the instruction defines as "an intent to deceive or cheat someone." That definitional language is the mens rea anchor the wire fraud counts must hit.
The healthcare fraud counts under 18 U.S.C. § 1347 carry the same heightened mens rea burden by statute. Section 1347 reaches only those who "knowingly and willfully" execute a scheme or artifice to defraud a health care benefit program. The "knowingly and willfully" language is a deliberate Congressional choice to require a culpable mental state above mere mistake or negligence. The false statements counts under 18 U.S.C. § 1035 require that the defendant "knowingly and willfully" made a material false statement in connection with the delivery of or payment for health care benefits.
The specific-intent-to-defraud standard does heavy work in a pure medical necessity case. The government must show that the defendant subjectively intended to deceive or cheat Medicare, not merely that the defendant submitted a claim that a Medicare contractor would later have denied. Where the coverage rule is contestable, where the LCD applied was selected by analogy rather than by its terms, and where the clinical judgment involved is genuinely debatable, the inference of intent to deceive or cheat is much harder to draw. A provider who exercised clinical judgment in good faith and believed the skin substitute application was medically appropriate did not act with specific intent to defraud, even where a Medicare contractor or a government expert would have reached a different clinical conclusion.
How an Experienced Defense Will Attack This Indictment
A skin substitute fraud case without a kickback allegation is built on a clinical foundation. That foundation is contestable in several ways.
Patient-by-Patient Clinical Defense
Because the indictment does not allege that any service was fabricated, the defense begins with the fact that real procedures were performed on real patients. The contest is over whether each beneficiary had a wound that justified advanced wound care. That contest is won, or lost, one patient at a time. A wound care expert reviews the full chart, the clinical course, the comorbidities, the prior failed conservative treatments, and the contemporaneous wound measurements and photographs. Where a Medicare beneficiary had a diabetic foot ulcer, a venous stasis ulcer, a pressure injury, or another chronic wound that had resisted conservative care, an experienced clinician can establish that skin substitute application fell within accepted medical practice.
Challenging the Coverage Interpretation
The government has applied a general wound care LCD to a specific advanced therapy that was not the subject of a controlling LCD in Utah during most of the charged period. The defense will scrutinize each charged claim against the actual language of any LCD in effect on the date of service, against contemporaneous CMS sub-regulatory guidance, and against the clinical standards of care in podiatric wound management. Where the government's coverage theory exceeds the contractor's published text, the medical necessity claim loses its anchor.
The Upcoding Theory and the Burden of Proving Wrongful Intent
To the extent the "not rendered as billed" language signals an upcoding theory, the government faces serious proof problems. Skin substitute claims are reimbursed by surface area applied, with CPT 15271 through 15278 distinguishing first-square-centimeter codes from add-on codes and differentiating among anatomic locations. HCPCS Q codes identify the specific product applied and are paired with the application code. An upcoding theory in a skin substitute case typically alleges one of three things: that the surface area in square centimeters reported on the claim exceeded what was applied to the wound, that the billed CPT code did not match the procedure performed or the anatomic location treated, or that the billed product Q code did not match the product actually used.
Each theory requires proof beyond a reasonable doubt that the defendant knew the billed code did not match the service performed. CPT coding for skin substitute applications involves clinical and coding judgment around wound surface area measurement, multi-wound aggregation, billing for product wastage under the JZ and JW modifiers, and selection of base versus add-on codes. CMS has issued successive guidance on the wastage modifiers because providers and coders have interpreted them inconsistently.
Honest coding errors are not crimes. A coding interpretation that a Medicare contractor disagrees with is not a crime. Where the defense can show that the provider's coding was consistent with a reasonable reading of the CPT and CMS guidance, the upcoding theory fails the scienter element of 18 U.S.C. § 1347.
Scope of Practice and the False Statements Counts
Counts 17 and 18 allege that Ellsworth signed patient charts falsely reflecting that he had provided services that, the government contends, were actually performed by an unqualified person. The defense will examine Utah's scope of practice rules for registered nurses and advanced practice registered nurses, the supervision arrangements actually in place, Medicare's "incident to" billing rules under 42 C.F.R. § 410.26, and whether the services as actually performed were appropriately documented as having been rendered "incident to" the supervising physician's care. Billing under the supervising physician's NPI for properly supervised services is not a false statement. It is how Medicare's incident-to framework was designed to work.
The Copayment Allegation Is Not a Standalone Crime
The indictment uses copayment waivers as a "manner and means" of the alleged fraud. The OIG has long taken the position that routine waiver of Part B copayments can implicate the Anti-Kickback Statute and the False Claims Act in certain circumstances. But the indictment does not charge a kickback violation. And copayment waivers driven by financial hardship, by demonstrated inability to collect, or by a good-faith billing practice are not, standing alone, evidence of criminal intent. The defense will examine each waiver in context.
Defendant-by-Defendant Intent Analysis
The government must prove beyond a reasonable doubt that each defendant knowingly participated in a scheme to defraud. Each defendant occupies a different position. A registered nurse who applied a skin substitute under a physician's order does not necessarily share the supervising podiatrist's billing intent. A nurse practitioner who exercised her own clinical judgment in selecting patients for advanced wound care is not a co-conspirator merely because the practice she worked in billed at high volume. The indictment does not allege any agreement between the three defendants. The defense will treat each defendant's intent separately.
The Charges and Maximum Penalties
The advisory Sentencing Guidelines range will be driven principally by loss under U.S.S.G. § 2B1.1. Loss is assessed defendant by defendant based on the conduct attributable to each. The indictment alleges that Medicare paid Summit approximately $19 million on claims tied to Ellsworth and approximately $10 million on claims tied to Kelly; Broadbent's charged counts allege approximately $102,000 in Medicare payments. Those figures, if proven, place each defendant in a different offense-level bracket before any role, abuse of trust, or sophisticated means enhancements. The guidelines are advisory under 18 U.S.C. § 3553(a).
What This Case Means for Other Wound Care Providers
The Ellsworth indictment confirms several enforcement realities for wound care providers, podiatrists, dermatologists, nurse practitioners, and clinic owners who bill skin substitutes to Medicare.
First, DOJ is prosecuting pure medical necessity theories without a kickback anchor. Any provider whose skin substitute billing volume is elevated faces exposure on that theory alone. Second, CMS's January 2026 reimbursement reduction does not protect providers from prosecution for prior-period billings. The Ellsworth indictment reaches conduct dating to July 2021. Third, the Fraud Section, HHS-OIG, and CMS Program Integrity continue to use data analytics to identify outliers, and the most recent indictments confirm that data-driven referrals are converting to charges across multiple districts.
Defending these cases requires lawyers who understand the LCD framework, the clinical standards of wound care medicine, the Medicare billing rules for advanced wound therapies, and the federal scienter standards the government must meet. Armstrong & Bradylyons PLLC defends providers in wound care and skin substitute fraud cases and across healthcare fraud defense matters nationwide.
Frequently Asked Questions
What is a skin substitute and why are skin substitute applications a federal healthcare fraud enforcement priority?
Skin substitutes are biologic wound care products derived from human or animal tissue applied to chronic wounds to promote healing. The category covers amniotic and placental allografts, dermal matrices, cellular and tissue-based products (CTPs), and bioengineered skin substitutes. Medicare reimburses these products under HCPCS Q codes paired with CPT application codes 15271 through 15278 for cellular and tissue-based skin substitute grafts.
CMS has reported that Medicare spending on skin substitutes rose from $256 million in 2019 to over $10 billion in 2024. DOJ's Fraud Section formalized the Wound Care Initiative in its 2025 Year in Review and now treats skin substitute billing as a top-tier criminal enforcement priority. Effective January 1, 2026, CMS revised the reimbursement methodology, projected to reduce program spending by nearly 90 percent. Federal skin substitute fraud investigations focus on medical necessity, documentation adequacy, qualifications of the rendering provider, and any wholesaler or distributor financial arrangement that may implicate the Anti-Kickback Statute.
Why does the absence of a kickback charge matter in a federal skin substitute fraud indictment?
In federal wound care fraud prosecutions, kickback allegations typically anchor the government's theory of intent. When prosecutors can show that referrals or product selections were driven by financial relationships with manufacturers, wholesalers, distributors, or sales representatives, juries are far more likely to infer fraudulent intent across every claim. Kickback evidence allows the government to argue the entire billing pattern was tainted from the outset.
Without an Anti-Kickback Statute count under 42 U.S.C. § 1320a-7b, the case reduces to a contest over clinical judgment. The government must prove, beneficiary by beneficiary and claim by claim, that the defendant knew the services were not medically necessary. Where the underlying coverage rules involve clinical thresholds, ambiguous Local Coverage Determinations, and interpretive judgment about which LCD applies, that proof is significantly harder to assemble at trial.
Do Local Coverage Determinations create criminal liability in skin substitute fraud cases?
Local Coverage Determinations (LCDs) are administrative coverage instructions issued by Medicare Administrative Contractors that explain when the contractor will pay for a particular service in a particular jurisdiction. They are not statutes. They are not federal regulations. A claim that does not satisfy an LCD may be denied at the claim level or recouped through administrative process. That is a payment dispute. Standing alone, it is not a federal crime.
To convert an LCD compliance issue into a criminal healthcare fraud case under 18 U.S.C. § 1347, the government must prove the defendant knew the claim was false and submitted it with specific intent to defraud Medicare. The Tenth Circuit Pattern Criminal Jury Instruction 2.57 defines specific intent to defraud as "an intent to deceive or cheat someone." Technical noncompliance with a contestable coverage document does not establish that mens rea. A provider who exercised clinical judgment in good faith did not act with specific intent to defraud Medicare.
What is LCD L38902 and how does the government use it to allege skin substitute fraud?
LCD L38902 is the "Wound and Ulcer Care" Local Coverage Determination issued by Noridian Healthcare Solutions, the Medicare Administrative Contractor for Utah and other western states. The document describes basic wound management standards, documentation requirements, and the clinical conditions under which advanced wound therapies may be considered after a period of failed conservative care. Its language references thirty days of basic wound management consisting of debridement, infection control, exudate management, and control of comorbid conditions before advanced wound care should be considered.
The Ellsworth indictment expressly states that no controlling LCD governed skin substitutes specifically in Utah during the charged period and applies L38902 by analogy to skin substitute applications. That interpretive choice is a vulnerable foundation. The defense will examine whether L38902 was the appropriate reference for skin substitute coverage, whether its language imposes the rigid thresholds the government attributes to it, and whether the clinical conditions of each charged patient satisfied accepted wound care standards regardless of any single LCD's general guidance.
How does the government prove medical necessity at trial in a federal wound care fraud case?
Federal prosecutors prove medical necessity through medical record review, claims data analytics from the HHS-OIG and DOJ's Health Care Fraud Data Fusion Center, and expert testimony from retained wound care physicians, plastic surgeons, vascular specialists, or podiatrists. The government highlights patterns such as high per-patient application counts, oversized skin substitute grafts relative to wound dimensions, abbreviated documentation, brief patient encounters, and treatment of patients whose wounds the government's expert concludes did not warrant advanced therapy.
The defense answers with independent wound care experts who review the same records and explain the clinical reasoning that supported each procedure. Contemporaneous documentation of wound measurements, comorbidities (diabetes, peripheral arterial disease, venous insufficiency), prior failed conservative treatments, and patient response carries significant weight. Where the defense expert credibly explains why skin substitute application fell within accepted practice for a particular patient, the government's burden of proving knowing fraud under 18 U.S.C. § 1347 fails.
Does the Ellsworth indictment allege that wound care services were never provided or fabricated?
No. The Ellsworth indictment does not allege phantom services, ghost patients, billing on dates when the clinic was closed, or applications of skin substitutes to patients with no wounds at all. The indictment does not allege that any service was entirely fabricated. The government's theory is that real procedures were performed on real patients but those patients (allegedly) did not meet the medical necessity threshold under LCD L38902, or that the services were performed by clinical staff outside their professional scope of practice and billed under the supervising physician's NPI.
That distinguishes Ellsworth from other federal skin substitute fraud indictments. The Gehrke and King prosecution in the District of Arizona alleged amniotic graft applications to wounds that were already healed or that did not exist. The June 2025 superseding indictment of Texas podiatrist David Jenson alleged skin substitute applications to patients "that did not have qualifying wounds, or any wounds at all." The Ellsworth defense begins from a contest over a contestable interpretation of medical necessity, not over whether the procedures occurred.
What are the elements of false statements relating to health care matters under 18 U.S.C. § 1035 in a skin substitute prosecution?
Counts 17 and 18 of the Ellsworth indictment charge under 18 U.S.C. § 1035(a)(2) for patient chart entries that allegedly misrepresented who furnished skin substitute services and whether Medicare requirements were satisfied. The statute reaches material false statements made in connection with the delivery of or payment for health care benefits and carries a five-year maximum sentence per count.
These are scope-of-practice charges in substance. The government's theory is that the supervising physician signed charts reflecting his personal performance of services that, in fact, were performed by a registered nurse outside the nurse's professional scope. The defense will examine Utah's scope of practice for registered nurses, Medicare's incident-to billing framework under 42 C.F.R. § 410.26, the actual supervision arrangements in place at the clinic, and whether each chart entry accurately reflected the supervising physician's involvement in the encounter. Properly supervised services billed under the supervising physician's NPI are not false statements.
How does the government prove upcoding in a federal skin substitute fraud case and what is the wrongful intent burden?
Upcoding in skin substitute fraud cases typically involves three theories: that the billed surface area in square centimeters exceeded the area actually applied to the wound, that the billed CPT application code (15271 through 15278) did not match the procedure performed or the anatomic location treated, or that the billed product HCPCS Q code did not match the product actually used. Reimbursement is driven by surface area, code selection, and product identification, so each theory produces a billing differential. The government uses claims data, medical records, photographs, and product invoices to compare what was billed against what the records reflect.
The wrongful intent burden is significant. Federal healthcare fraud under 18 U.S.C. § 1347 requires proof beyond a reasonable doubt that the defendant knew the billed code did not match the service performed. CPT coding for skin substitutes involves clinical and coding judgment around wound surface area measurement, multi-wound aggregation, product wastage billing under the JZ and JW modifiers, and the selection of base codes versus add-on codes. CMS has issued successive guidance on the wastage modifiers because providers and coders have interpreted them inconsistently. Honest coding errors and good-faith interpretations are not crimes.
How do Medicare copayment waivers factor into a federal healthcare fraud indictment?
Medicare expects participating providers to collect Part B copayments and to make good-faith efforts to do so. HHS-OIG's 1994 Special Fraud Alert states that routine waiver of Part B copayments can implicate the Anti-Kickback Statute and the False Claims Act in certain circumstances. The underlying theory is that consistent copayment collection gives beneficiaries a financial reason to refuse unnecessary services and therefore operates as a fraud deterrent.
Copayment waivers, standing alone, are not a federal crime. They become criminally relevant only when paired with other proof of fraudulent intent. Waivers based on documented financial hardship, on good-faith billing practices, or on bona fide collection difficulties do not support an inference of criminal intent under 18 U.S.C. § 1347. The Ellsworth indictment uses copayment waivers as a "manner and means" allegation, not as a standalone charge. Wound care fraud defense counsel will place each waiver in its actual operational and clinical context.
How does Medicare's "incident to" billing rule apply in a skin substitute fraud defense?
Medicare's incident-to billing rule at 42 C.F.R. § 410.26 permits services furnished by certain auxiliary personnel to be billed under a supervising physician's National Provider Identifier when specific regulatory conditions are met. Direct physician supervision and an integral, although incidental, relationship to the physician's professional service are among the required conditions. Properly executed incident-to billing is how the Medicare program is designed to operate.
When the government alleges that services were "outside the professional scope" of a nurse practitioner, registered nurse, or other clinical staff member and improperly billed under a physician's NPI, the defense examines whether incident-to billing would have been appropriate had the supervision and scope-of-practice conditions been satisfied. State scope of practice and federal billing rules interact in technical ways. Misunderstanding which services may be billed under whose number is common in clinical practice. It is not the same as criminal healthcare fraud, which requires proof of specific intent to defraud Medicare.
What is the role of criminal forfeiture and asset seizure in a skin substitute fraud case?
Federal skin substitute fraud indictments routinely include forfeiture allegations under 18 U.S.C. § 982(a)(7) for the health care fraud and false statements counts and under 18 U.S.C. § 981(a)(1)(C) and 28 U.S.C. § 2461(c) for the wire fraud counts. The government can seek a money judgment equal to gross proceeds traceable to the offense and pursue substitute assets under 21 U.S.C. § 853(p) when original proceeds cannot be located. Pretrial seizure warrants are common.
The Supreme Court's decision in Honeycutt v. United States, 581 U.S. 443 (2017), limits joint and several forfeiture liability among co-defendants. Each defendant is generally liable only for proceeds the defendant personally acquired. That matters when a wound care indictment names a physician owner, a nurse practitioner, and a registered nurse with substantially different financial roles.
What experience does Armstrong & Bradylyons PLLC bring to a federal wound care fraud or skin substitute fraud defense?
Armstrong & Bradylyons PLLC defends physicians, podiatrists, nurse practitioners, registered nurses, clinic owners, and healthcare executives in federal wound care fraud and skin substitute fraud investigations and prosecutions nationwide. Scott Armstrong is a former Assistant Chief at DOJ's Fraud Section. He tried sixteen complex federal cases in courts across the country, including nine healthcare fraud jury trials, and served as lead counsel in healthcare fraud cases totaling over $600 million in alleged false claims to Medicare, Medicaid, and TRICARE. He has tried cases under the precise statutes charged in the Ellsworth indictment, including 18 U.S.C. § 1347, 18 U.S.C. § 1343, and 18 U.S.C. § 1035.
Drew Bradylyons is a former Assistant Chief at DOJ's Fraud Section who supervised the Healthcare Fraud Unit's South Florida Strike Force, where he investigated and supervised cases involving more than $1 billion in fraudulent claims to federal health care programs. He later served as Chief of the Financial Crimes and Public Corruption Unit at the U.S. Attorney's Office for the Eastern District of Virginia. Together with Special Counsel Andrea Savdie, the firm's attorneys have over 25 years of combined DOJ experience, participated in 25 federal jury trials, and tried 17 healthcare fraud cases involving over $2.8 billion in alleged false claims. The firm represents healthcare executives in DOJ Wound Care Initiative investigations from grand jury through trial.
In what federal jurisdictions does Armstrong & Bradylyons PLLC defend wound care and skin substitute fraud cases?
Based in Washington, D.C., Armstrong & Bradylyons PLLC defends healthcare executives, clinic owners, podiatrists, dermatologists, nurse practitioners, and registered nurses in federal wound care fraud and skin substitute fraud cases nationwide. The firm practices in every federal district court in the country, matching the geographic reach Scott Armstrong and Drew Bradylyons had while leading cases for DOJ's Fraud Section Healthcare Fraud Unit.
The DOJ Health Care Fraud Strike Force operates in the Southern District of Florida, the Eastern District of Michigan, the Southern District of Texas, the Central District of California, the District of Massachusetts, the Northern District of Illinois, the District of New Jersey, the Eastern District of New York, the Middle District of Louisiana, and additional federal districts. Wound Care Initiative investigations have generated indictments in the District of Arizona, the Southern District of Texas, the District of Utah, the Central District of California, and other districts. Armstrong & Bradylyons PLLC represents clients in every federal jurisdiction where DOJ brings healthcare fraud and Anti-Kickback Statute cases.
Facing a Federal Wound Care or Skin Substitute Fraud Investigation?
Armstrong & Bradylyons PLLC defends podiatrists, dermatologists, nurse practitioners, registered nurses, and wound care clinic owners in federal investigations and prosecutions involving skin substitute billing, medical necessity, and scope of practice. As former senior officials of DOJ's Fraud Section, Scott Armstrong and Drew Bradylyons understand how the government builds these cases and where the defense weaknesses lie. The firm provides trial-ready defense in complex healthcare fraud matters nationwide.
